Pericyte Migration: A Novel Mechanism of Pericyte Loss in Experimental Diabetic Retinopathy by Pfister, Frederick et al.
Pericyte Migration
A Novel Mechanism of Pericyte Loss in Experimental
Diabetic Retinopathy
Frederick Pﬁster,
1 Yuxi Feng,
1 Franziska vom Hagen,
1,3 Sigrid Hoffmann,
2 Grietje Molema,
3
Jan-Luuk Hillebrands,
4 Moshe Shani,
5 Urban Deutsch,
6 and Hans-Peter Hammes
1
OBJECTIVE—The mechanism underlying pericyte loss during
incipient diabetic retinopathy remains controversial. Hyperglyce-
mia induces angiopoietin-2 (Ang-2) transcription, which modu-
lates capillary pericyte coverage. In this study, we assessed loss
of pericyte subgroups and the contribution of Ang-2 to pericyte
migration.
RESEARCH DESIGN AND METHODS—Numbers of total
pericytes and their subgroups were quantiﬁed in retinal digest
preparations of spontaneous diabetic XLacZ mice. Pericytes
were divided into subgroups according to their localization, their
position relative to adjacent endothelial cells, and the expression
of LacZ. The contribution of Ang-2 to pericyte migration was
assessed in Ang-2 overexpressing (mOpsinhAng2) and deﬁcient
(Ang2LacZ) mice.
RESULTS—Pericyte numbers were reduced by 16% (P  0.01)
in XLacZ mice after 6 months of diabetes. Reduction of pericytes
was restricted to pericytes on straight capillaries (relative reduc-
tion 27%, P  0.05) and was predominantly observed in LacZ-
positive pericytes (20%, P  0.01). Hyperglycemia increased
the numbers of migrating pericytes (69%; P  0.05), of which the
relative increase due to diabetes was exclusively in LacZ-nega-
tive pericytes, indicating reduced adherence to the capillaries
(176%; P  0.01). Overexpression of Ang-2 in nondiabetic retinas
mimicked diabetic pericyte migration of wild-type animals (78%;
P  0.01). Ang-2 deﬁcient mice completely lacked hyperglyce-
mia-induced increase in pericyte migration compared with wild-
type littermates.
CONCLUSIONS—Diabetic pericyte loss is the result of pericyte
migration, and this process is modulated by the Ang-Tie system.
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ericytes are heterogeneous with regard to their
origin, distribution, phenotype, and function
(1,2). Resident retinal pericytes derive from me-
soderm and neural crest during development. A
bone marrow origin of pericytes and transdifferentiation
of endothelial cells into pericytes have also been de-
monstrated during postnatal vascular repair and in adult
angiogenesis (3–5). Furthermore, pericytes can transdif-
ferentiate into macrophage- and ﬁbroblast-like cells (6,7).
Pericytes are the capillary counterparts to smooth muscle
cells (SMCs) on arterioles. In contrast to SMCs, they are
completely embedded within the capillary basement mem-
brane and extend processes, varying in length, arrange-
ment, and form, indicating their mobility in functional
blood vessels (8–11). One remarkable common feature of
pericytes and SMCs is their contractile phenotype (12).
However, the key molecules actin and myosin for vessel
constriction are unequally distributed within the pericyte
population (13–15), leading to differences in their contrac-
tive potential, depending on their localization within the
capillary tree (12). Pericytes can control endothelial cell
proliferation and angiogenesis, both under physiological
and pathological conditions (16–22). Smooth muscle actin
(SMA), desmin, proteoglycan NG2, platelet-derived growth
factor receptor  (PDGFB-R), the aminopeptidase N, and
the regulator of G-signaling 5 (RGS-5) are common peri-
cyte markers, but none of them is sufﬁcient to recognize
every pericyte (15,19,23–29). Another experimental tool
for studying pericytes is the XLacZ mouse. In this mouse,
LacZ is expressed in vascular SMCs and pericytes at
distinct levels of the vascular tree, but cell proliferation
and migration are associated with transgene downregula-
tion. To our own observations, LacZ is expressed only in a
subset of retinal pericytes. The diversity of origin, differ-
ences in functional capacity, and the lack of a pan-
pericyte marker suggest that the pericyte population is
not uniform in a given organ; hence, the response of retinal
pericytes on chronic hyperglycemia may differ in certain
subpopulations.
Diabetic retinopathy is morphologically characterized
by pathological changes in the retinal capillaries. The
primary and predominant characteristics are the loss of
pericytes and the progressive occlusion of capillaries
(8,30). It is presumed that prevention of the earliest events
in the pathogenesis of diabetic retinopathy, such as peri-
cyte loss, will prevent the subsequent development of
diabetic retinopathy. The underlying mechanisms respon-
sible for pericyte loss in diabetic retinopathy are complex
and not completely elucidated.
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DIABETES, VOL. 57, SEPTEMBER 2008 2495Apoptosis and destructive signaling pathways within
pericytes are generally discussed to be the reasons for
retinal pericyte loss under hyperglycemic conditions
(31,32), but growing evidence suggests that pericytes are
actively depleted by alternative mechanisms. Pericyte cov-
erage of capillaries is modulated by a variety of growth
factors systems, such as angiopoietins and their tyrosine
kinase receptor Tie-2. Angiopoietin-2 (Ang-2) is expressed
in the retina and is upregulated in the diabetic retina,
before pericyte loss. We recently demonstrated that a 50%
reduction of the Ang-2 gene dose prevents pericyte loss in
the diabetic retina, suggesting an important role of the
Ang-2/Tie-2 system in diabetic pericyte loss. Constitutive
overexpression of Ang-2 in photoreceptor cells reduces
pericyte coverage in the deep capillary layers of the retina,
and injection of recombinant Ang-2 into the vitreous of
nondiabetic rats induced a dose-dependent pericyte loss
within days, indicating the importance of Ang-2 in the
reduction of pericyte coverage (33,34). Increased levels of
Ang-2 in diabetic animals and in vitreous ﬂuid of patients
with proliferative diabetic retinopathy support the role of
the Ang-2/Tie-2 system in the pathogenesis of diabetic
retinopathy (35,36), but the underlying mechanisms re-
main to be investigated.
In light of published evidence for the heterogeneity of
pericytes and the association of pericyte loss with the
Ang-2/Tie-2 system, we hypothesized that diabetic pericyte
loss is the result of mechanisms other than apoptosis in
situ and that factors such as Ang-2 may actively modulate
this process.
In this study, we used transgenic mouse models for
quantiﬁcation of pericyte loss in experimental diabetic
retinopathy to investigate the response of retinal pericytes
to chronic hyperglycemia and the effect of Ang-2 on retinal
pericyte migration in gain- and loss-of-function models.
RESEARCH DESIGN AND METHODS
All experiments in this study were performed according to the guidelines of
the statement of animal experimentation issued by the Association for
Research in Vision and Ophthalmology (ARVO) and were approved by the
Institutional Animal Care and Use Committee. Animals were housed in groups
in cages with free access to standard food and water under a 12-h light and
12-h dark rhythm.
Spontaneous diabetic Ins2Akita heterozygous mice, purchased from Jack-
son Laboratory (Charles River Laboratories, Sulzfeld, Germany) were bred
with homozygous XLacZ mice, which express the reporter gene LacZ under
the control of a smooth muscle and pericyte-speciﬁc promoter (29) to
generate spontaneous diabetic heterozygous XLacZ mice (Ins2Akita
/
XLacZ
/). Age-matched nondiabetic heterozygous XLacZ mice (Ins2Akita
/
XLacZ
/) served as control. Genotype was determined by PCR 4 weeks after
birth as described previously (37). Only male mice were used in this study,
since the diabetes onset is earlier and hyperglycemia is more severe compared
with female mice. Glucose levels and body weight were monitored consecu-
tively every other week, and glycated hemoglobin concentration was deter-
mined by afﬁnity chromatography at the end of the study (MicromatII; Bio-Rad
Laboratories, Munich, Germany). Insulin was occasionally given to individual
diabetic mice to prevent critical weight loss. After 6 months of experimental
diabetes, eyes were enucleated under deep anesthesia and immediately frozen
at 80°C for further analysis.
To study the impact of Ang-2 on pericyte migration, retinas of transgenic
mOpsinAng2 and Ang2LacZ mice were analyzed. mOpsinhAng2 mice overex-
press human Ang-2 in the photoreceptor layer of the retina. Ang2LacZ mice
carry a targeting vector that replaces part of the coding region of Ang-2, with
the LacZ gene encoding -galactosidase with the intention of creating a null
allele of Ang-2. Heterozygous LacZ knock-in results in a 50% reduction of
functional Ang-2 gene dose. Generation and genotyping of mOpsinAng2 and
Ang2LacZ mice have been described previously (34,38). Wild-type litters
served as controls. Diabetes was induced by a single injection of streptozo-
tocin (STZ) (purchased from Roche Diagnostics, Mannheim, Germany; 150
mg/kg i.p.) in randomly selected animals of transgenic and WT (wild-type)
mice. STZ-injected animals were considered diabetic when blood glucose
levels reached stable levels 250 mg/dl. Diabetic and nondiabetic mice were
killed 6 months after diabetes induction, and eyes were collected under deep
anesthesia and immediately frozen at 80°C.
LacZ staining. Eyes of XLacZ mice were stained for -galactosidase activity
according to an established protocol (33). In brief, eyes were ﬁrst ﬁxed
(phosphate buffer 100 mmol/l, pH 7.3, containing 1.5% [vol/vol] formaldehyde/
0.2% [vol/vol] glutaraldehyde) and then incubated in a staining solution
containing 0.1% X-gal (Roche Diagnostics), 5 mmol/l K4Fe(CN)6, and 5 mmol/l
K3Fe(CN)6 overnight at 37°C. After washing in PBS, retinas were isolated and
subjected to the retinal digestion procedure (see below).
Immunoﬂuorescence analysis. To examine the relationship of migrating
pericytes with the underlying endothelium, retinal whole mounts ﬁxed in 4%
paraformaldehyde were permeabilized in 1% BSA and 0.5% Triton X-100 at
room temperature for 1 h and incubated with a rabbit anti-NG2 chondroitin
sulfate proteoglycan polyclonal antibody (Chemicon International, Hamp-
shire, U.K.; dilution 1:200) and tetramethylrhodamine isothiocyanate (TRITC)-
labeled isolectin B4 from Bandeiraea simplicifolia (Sigma-Aldrich, Mu ¨nchen,
Germany; dilution 1:50) overnight at 4°C. Fluorescein isothiocyanate–conju-
gated swine anti-rabbit IgG (DakoCytomation, Hamburg, Germany; dilution
1:20) was used for the detection of NG2 primary antibody. Photos were taken
using a confocal microscope (Leica TCS SP2 Confocal Microscope; Leica).
Retinal digest preparations. Vascular preparations of whole-mount retinas
of XLacZ, mOpsinhAng2, and Ang2LacZ mice were performed using a trypsin
digestion technique as previously described (8,33). Brieﬂy, retinas were
digested in a solution containing 3% trypsin resolved in 0.2 mol/l Tris-HCl
solution at 37°C for 3 h. The retinal vasculature was isolated by dropping
water and dried on objective slides. Subsequently, retinal digest samples were
stained with periodic acid Schiff base (39) and hematoxylin.
Morphological quantiﬁcation. To determine numbers and morphologies of
retinal pericytes, retinal digest preparations of spontaneous diabetic and
nondiabetic XLacZ mice (n  7–8) were analyzed. First, total numbers of
pericytes were counted in 10 randomly selected areas (magniﬁcation 400)i n
the middle sector of the retina, using an image analyzing system (CUE-2;
Olympus Opticals, Hamburg, Germany). Both areas, close to the optic nerve
and to the external border of the retina, were excluded from analysis.
Numbers were standardized relative to the capillary density (numbers of cells
per mm
2 of capillary area). Subsequently, according to their localization
within the capillary tree and their position relative to adjacent endothelial
cells, pericytes were divided into three subgroups. Pericytes were located
either at capillary branches (B-PC) or on straight capillaries (S-PC) with broad
contact to the underlying endothelium, or on straight capillaries with less area
of contact to the microvasculature (M-PC). Pericytes with triangular nuclei,
migrating from capillaries into the extravascular interstitium, were deﬁned as
M-PCs, since at least one lateral side of the triangular nuclei was longer than
the basis in contact to the capillary. Migrating pericytes usually extended
processes to neighboring capillaries. Finally, according to the LacZ staining,
each group described above was divided into two subgroups, e.g., B-PC into
B-PC
 (i.e., pericytes at branches stained positive for LacZ) and B-PC
 (i.e.,
LacZ-negative pericytes at branches). The numbers of pericytes in 10 ran-
domly selected ﬁelds of the retina were standardized relative to the capillary
density (number of cells per mm
2 of capillary area). All samples were
evaluated in a masked fashion.
To examine the inﬂuence of the Ang-2/Tie-2 system on pericyte loss in
diabetic retinopathy, we quantiﬁed the numbers of migrating pericytes (M-
PCs) in retinas of nondiabetic and diabetic mOpsinhAng2 (n  7–8 animals
per group) and Ang2LacZ mice (n  6) in comparison to nondiabetic and
diabetic WT litters (n  8).
Statistical analysis. Quantitative data are given as means  SD. Student’s t
test was used to make comparison between groups. A value of P  0.05 was
considered statistically signiﬁcant.
RESULTS
Metabolic data of XLacZ mice, mOpsinhAng2, and
Ang2LacZ mice. Diabetic XLacZ mice developed elevated
blood glucose levels after the fourth postnatal week. Two
weeks later, most diabetic males reached stable blood
glucose levels 500 mg/dl. Final blood glucose was signif-
icantly elevated in diabetic XLacZ mice (nondiabetic ver-
sus diabetic XLacZ mice: 147.1  17.9 and 599.8  0.7
mg/dl; P  0.001) compared with nondiabetic XLacZ mice.
At the end of the study, diabetic XLacZ mice showed a 32%
reduced body weight compared with nondiabetic XLacZ
mice (nondiabetic versus diabetic XLacZ mice: 35.9  4.7
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were 2.2-fold increased in diabetic XLacZ mice compared
with nondiabetic mice (nondiabetic versus diabetic XLacZ
mice: 5.8  0.6 and 12.8  1.8%; P  0.01, Table 1).
After 6 months of hyperglycemia, diabetic mOpsin-
hAng2 mice showed signiﬁcantly elevated levels of blood
glucose (nondiabetic versus diabetic mOpsinhAng2 mice:
184.6  19.0 and 575.0  40.9 mg/dl, P  0.001) and A1C
(nondiabetic versus diabetic mOpsinhAng2 mice: 5.7  0.5
and 10.7  2.1%, P  0.001) compared with their nondia-
betic litters. Body weights of diabetic mOpsinhAng2 mice
were signiﬁcantly reduced (nondiabetic versus diabetic
mOpsinhAng2 mice: 34.5  4.6 and 28.0  3.9 g, P  0.01,
Table 1).
In diabetic Ang2LacZ mice, ﬁnal blood glucose levels
and A1C were also signiﬁcantly increased (nondiabetic
versus diabetic Ang2LacZ: 165.5  26.1 and 582.7  42.5
mg/dl blood glucose, P  0.001, and 5.4  0.1 and 11.1 
1.9% A1C, P  0.01), and chronic hyperglycemia led to
weight loss of 29% in diabetic Ang2LacZ mice (nondiabetic
versus diabetic Ang2LacZ: 34.2  3.5 and 24.3  4.5 g, P 
0.05, Table 1).
Differential pericyte loss in a pericyte subpopulation.
Pericytes show variable phenotypes. As demonstrated in
Fig. 1A, pericytes were located either at capillary branches
or on straight capillaries. Pericytes on straight capillaries
showed small, round, or elongated nuclei. Notably, one
type of pericyte on straight capillaries appeared to have
less contact to the endothelium. Figure 1B–G illustrate a
pericyte migration continuum process from broad to less
contact to the underlying endothelium, which we fre-
quently found at different stages in our studies. Pericytes
in Fig. 1D–G were deﬁned as migrating pericytes. To
examine the relationship between pericyte and the adja-
cent endothelium during the migration process and to
exclude artifacts of the digestion procedure, NG2 (green)/
lectin (red) double stainings of retinal whole mounts were
performed (Fig. 1H–J). In contrast to pericytes located on
capillaries, migrating pericytes and their extensions to
neighboring vessels were solely positive for NG2, suggest-
ing that these structures derive from pericytes and that
this pericyte phenotype is neither the consequence of
vasoregression nor due to the digestion procedure.
To assess the effect of elevated blood glucose on
pericyte loss, we analyzed pericyte coverage in retinal
digest preparations of diabetic XLacZ mice after 6 months
of experimental hyperglycemia. We found a 16% reduction
of total pericyte numbers after 6 months of hyperglycemia
in diabetic XLacZ mice compared with their nondiabetic
littermates (nondiabetic versus diabetic: 2,374  257 and
2,002  136 per mm
2 of capillary area, P  0.01, Fig. 2A).
Analysis of pericyte subgroups revealed that pericytes on
vessel branches (B-PCs) were completely unaffected by
chronic hyperglycemia (nondiabetic versus diabetic:
580  157 and 586  139 per mm
2 of capillary area, Fig.
2B). We found that the loss of pericytes in diabetic retinas
was limited to pericytes on straight capillaries (S-PCs).
Numbers of S-PCs were reduced by 27% (nondiabetic
versus diabetic: 1,676  316 and 1,218  282 per mm
2 of
capillary area; P  0.05, Fig. 2C), and this reduction
completely explained the reduction in total pericyte num-
bers in diabetic animals. Hyperglycemia-induced reduc-
tion of pericytes was due to a loss of pericytes located on
straight capillaries, accompanied by increased numbers of
pericytes detaching preferably from straight parts of reti-
nal capillaries. Hyperglycemia led to increased numbers of
pericytes that were involved in morphologically deﬁned
migration processes (M-PC). The numbers of M-PCs in-
creased by 69% in diabetic XLacZ retinas after 6 months
of hyperglycemia compared with nondiabetic XLacZ reti-
nas (nondiabetic versus diabetic: 117  38 and 198  79
per mm
2 of capillary area; P  0.05, Fig. 2D).
Furthermore, we analyzed pericyte loss in different
pericyte subpopulations according to LacZ expression in
XLacZ mice. In each subgroup mentioned above, there
were LacZ-positive and -negative pericytes, as shown in
Fig. 3A–F. Of total pericytes, 52% were stained LacZ
positive, both in nondiabetic and diabetic retinas, but only
LacZ-positive pericytes were signiﬁcantly reduced. LacZ-
positive pericytes showed a reduction of 20% (nondiabetic
versus diabetic: 1,258  134 and 1,008  172 per mm
2 of
capillary area; P  0.01, Fig. 4A). Numbers of LacZ-
negative pericytes were only insigniﬁcantly changed (non-
diabetic versus diabetic: 1,115  158 and 994  110 per
mm
2 of capillary area; P  0.05, Fig. 4A). There was no
change in the numbers of LacZ-positive and LacZ-negative
B-PCs (Fig. 4B). The reduction of S-PCs was due to a
signiﬁcant loss of LacZ-positive and LacZ-negative peri-
TABLE 1
Metabolic data of nondiabetic and diabetic XLacZ, mOpsinhAng2, and Ang2LacZ mice
Nondiabetic XLacZ Diabetic XLacZ
n 11 8
Glucose level (mg/dl) 147.1  17.9 599.8  0.7*
Body weight (g) 35.9  4.7 24.3  3.3*
A1C (%) 5.8  0.6 12.8  1.8*
Nondiabetic mOpsinhAng2 Diabetic mOpsinhAng2
n 78
Glucose level (mg/dl) 184.6  19.0 575.0  40.9†
Body weight (g) 34.5  4.6 28.0  3.9*
A1C (%) 5.7  0.5 10.7  2.1†
Nondiabetic Ang2LacZ Diabetic Ang2LacZ
n 66
Glucose level (mg/dl) 165.5  26.1 582.7  42.5§
Body weight (g) 34.2  3.5 24.3  4.5*
A1C (%) 5.4  0.1 11.1  1.9†
Metabolic data of nondiabetic and diabetic mice. Diabetic XLacZ (*P  0.001), mOpsinhAng2 (*P  0.01, †P  0.001), and Ang2LacZ mice
(*P  0.05, †P  0.01, §P  0.001) were compared with their nondiabetic litters.
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DIABETES, VOL. 57, SEPTEMBER 2008 2497cytes (Fig. 4C). LacZ-positive S-PCs were reduced by 32%
(nondiabetic versus diabetic: 799  152 and 543  181 per
mm
2 of capillary area; P  0.05) and LacZ-negative S-PCs
were reduced by 23% in diabetic animals (nondiabetic
versus diabetic: 878  188 and 674  145 per mm
2 of
capillary area; P  0.05). Increased numbers of M-PCs rose
from pericytes that were negative for LacZ expression.
LacZ-negative M-PCs increased over 2.5-fold (nondiabetic
versus diabetic: 21  10 vs. 79  43 per mm
2 of capillary
area; P  0.01) in diabetic retinas (Fig. 4D).
Inﬂuence of Ang-2 modulation on pericyte migration.
The Ang-Tie system is crucially involved in pericyte re-
cruitment and attachment. Ang-2 is upregulated by hyper-
glycemia. Therefore, we examined the effect of Ang-2
changes on pericyte migration (Fig. 5).
As expected, diabetic WT mice showed signiﬁcantly
increased numbers of migrating pericytes up to 70% com-
pared with nondiabetic WT mice (nondiabetic WT versus
diabetic WT: 51  7 and 86  19 pericyte per mm
2 of
capillary area; P  0.001). Therefore, the extent of in-
creased pericyte migration in streptozotocin-induced dia-
betic animals was comparable to that observed in
spontaneous diabetic XLacZ mice. Overexpression of
Ang-2 in nondiabetic retinas was sufﬁcient to mimic retinal
pericyte migration of diabetic WT litters with increased
numbers of migrating pericytes of 78% (nondiabetic WT
A
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FIG. 1. Illustration of pericyte subpopulations according to their location and contact to capillaries (A) and of pericyte migration process (B–G)
in retinal digest preparations. Arrow in A: B-PCs, pericytes at branches; arrowhead in A: S-PCs, pericytes on straight capillaries with broad
contact to endothelium; asterisks in A: M-PCs, migrating pericytes on straight capillaries with less contact to endothelium. The continuum of
pericyte migration process is depicted in Fig. 1B–G. According to our morphological deﬁnition, pericytes were considered as migrating pericytes
(M-PCs), since at least one lateral side of the triangular nuclei was longer than the basis in contact to the capillary (Fig. 1D–G). Migrating
pericytes usually extended processes to neighboring capillaries. Confocal microscopy of NG2 (green)/lectin (red) stained retinal whole mounts
identiﬁed pericytes (arrows in H–J) and their processes to be dissociated from the underlying endothelium (Fig. 1H–J). H: NG2–ﬂuorescein
isothiocyanate staining; I: lectin-TRITC staining; J: merged image of H and I. Original magniﬁcation: 400. (Please see http://dx.doi.org/10.2337/
db08-0325 for a high-quality digital representation of this ﬁgure.)
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2498 DIABETES, VOL. 57, SEPTEMBER 2008versus nondiabetic mOpsinhAng2: 51  7 and 90  26
pericyte per mm
2 of capillary area; P  0.01). Further-
more, overexpression of Ang-2 in diabetic mice increased
the numbers of migrating pericytes by 2.3-fold compared
with nondiabetic WT mice (nondiabetic WT versus dia-
betic mOpsinhAng2: 51  7 and 118  25 pericyte per mm
2
of capillary area; P  0.0001) and by 37% compared with
diabetic WT litters (diabetic WT versus diabetic mOpsin-
hAng2: 86  19 and 118  25 pericyte per mm
2 of capillary
area; P  0.05). Quantitation of pericyte migration in
nondiabetic Ang-2–deﬁcient mice showed a signiﬁcant
reduction of 36% (nondiabetic WT versus nondiabetic
Ang2LacZ: 51  7 and 37  10 pericyte per mm
2 of
capillary area; P  0.05) compared with nondiabetic WT
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FIG. 2. Quantitation of pericyte subpopulations in nondiabetic and diabetic XLacZ mice. Total numbers of pericytes (T-PC, A), numbers of
pericytes at branches (B-PC, B), pericytes on straight capillaries with broad contact to endothelium (S-PC, C), and migrating pericytes (M-PC,
D) in nondiabetic and diabetic XLacZ mice (, nondiabetic; f, diabetic) after 6 months of hyperglycemia are shown. *P < 0.05, †P < 0.01.
FIG. 3. Illustration (A–F) of pericyte subpopulations considering their location and LacZ expression in XLacZ retinas. Pericytes at branches (A
and D), pericytes on straight capillaries with broad contact to endothelium (B and E), and migrating pericytes (C and F) were divided into
LacZ-positive (e.g., T-PC
, D–F) and LacZ-negative (e.g., T-PC
, A–C) stained pericytes. Original magniﬁcation 400. (Please see http://
dx.doi.org/10.2337/db08-0325 for a high-quality digital representation of this ﬁgure.)
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lacked a hyperglycemia-induced increase in pericyte mi-
gration (diabetic WT versus diabetic Ang2LacZ: 86  19 vs.
52  15 pericyte per mm
2 of capillary area; P  0.01)
compared with diabetic WT litters. Nevertheless, hypergly-
cemia slightly enhanced pericyte migration in Ang2LacZ
mice (nondiabetic Ang2LacZ vs. diabetic Ang2LacZ: 37  10
vs. 52  15 pericyte per mm
2 of capillary area).
DISCUSSION
In this study, we describe a novel mechanism of pericyte
loss in experimental diabetic retinopathy. We demon-
strated that pericyte loss in diabetic retinopathy is re-
stricted to a subset of pericytes located on straight
capillaries. Hyperglycemia-induced loss of pericytes, pre-
dominantly on straight capillaries, is accompanied by
increased numbers of pericytes, migrating from the same
location into the perivascular position. Increased numbers
of migrating pericytes are LacZ negative. Furthermore, we
show that Ang-2 is crucial for pericyte migration, since
Ang-2–deﬁcient mice completely lack hyperglycemia-in-
duced pericyte migration, whereas overexpression of
Ang-2 mimics increased pericyte migration observed in
diabetic retinas.
Experimental long-term hyperglycemia enhances peri-
cyte detachment, leading to reduced pericyte coverage of
retinal capillaries. Growing evidence suggests that peri-
cyte detachment and migration from underlying vessels
into the perivascular parenchym is a general feature of
pericytes in response to different kinds of stress inducers.
In brain capillaries, pericytes migrate from capillaries as a
result of ischemia, hypoxia, or injury (40,41). In response
to traumatic brain injury, 	40% of capillary pericytes
migrated from their microvascular location and remained
in a perivascular position, while remaining pericytes on
capillaries displayed signs of degeneration. In tracheal
capillaries, blockage of VEGF signaling resulted in migra-
tion of pericytes from the regressing capillaries onto
surviving vessels, leaving behind empty basement mem-
brane tubes, comparable to those observed in diabetic
retinopathy (42). These data show that pericyte attach-
ment is actively modulated depending on environmental
conditions.
In the diabetic retina, pericyte loss is one of the earliest
and most characteristic morphological changes. Our pre-
vious data revealed the importance of the Ang-2/Tie-2
system in the regulation of vascular morphological
changes in the diabetic retina. In diabetic rat retina, Ang-2
is upregulated before pericyte loss becomes evident, and
increased expression of Ang-2 correlates with the deple-
tion of perivascular cells (33,35). Intravitreal injection of
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ciency appears to protect against diabetes-induced peri-
cyte dropout. Now, we show that Ang-2 regulates pericyte
migration in experimental diabetic retinopathy. In loss of
function experiments, we show that Ang-2 is required for
hyperglycemia-induced migration of pericytes, since Ang-
2–deﬁcient mice lack increased migration of pericytes
compared with diabetic WT mice. In addition, gain of
function experiments showed that overexpression of
Ang-2 enhances pericyte migration in nondiabetic and
diabetic animals. The extent of pericyte migration, in-
duced by Ang-2 overexpression in nondiabetic retinas, was
similar to the one observed in WT diabetic animals,
highlighting the importance of the Ang-Tie system in
cellular crosstalk and its involvement in the earliest stages
of diabetic retinopathy. Nevertheless, we found a trend for
a hyperglycemia-induced increase in pericyte migration in
Ang-2–overexpressing and –deﬁcient retinas, suggesting
that other factors than Ang-2 may be of some importance
for pericyte migration. Recent observations in microvas-
cular endothelial cells revealed that high glucose increases
the expression of Ang-2 through modiﬁcation of corepres-
sor mSim3A by methylglyoxal, an important intracellular
advanced glycation end product (AGE) (43). Because
methylglyoxal is the predominant intracellular AGE in the
diabetic retina, this study links biochemical changes of
diabetes to increased activation of the Ang-2/Tie-2 system
and therefore to our observation that hyperglycemia en-
hances detachment and migration of pericytes from micro-
vasculature, resulting in the typical pericyte loss of
diabetic retinopathy.
Moreover, our data demonstrate that hyperglycemia-
induced loss of pericytes is not equal in retinal pericyte
subpopulations, such as it is restricted to pericytes located
on straight capillaries of the retinal microvasculature.
Straight capillaries are the only sites from which pericytes
migrate. According to our observations, hyperglycemia
reduces the number of S-PCs by 	460 cells per mm
2 of
capillary area after 6 months of hyperglycemia and simul-
taneously increases the numbers of migrating pericytes by
	80 cells per mm
2 of capillary area. The gap between the
numbers of lost and migrating pericytes is partly explained
by the digestion process, since this eliminates pericytes
that are completely dissociated. Furthermore, the retinal
digest preparations represent snapshots of the perma-
nently remodeling vasculatures. The quantitative contribu-
tion of pericyte migration to pericyte loss in experimental
diabetic retinopathy and the destiny of dissociated peri-
cytes remain to be established.
LacZ in XLacZ mice labels 	52% of all pericytes and is
therefore a restricted pericyte marker, such as others.
Nevertheless, quantitation of total pericyte numbers and
the expression of LacZ showed that only LacZ-positive
pericytes are signiﬁcantly reduced in diabetic retinas.
Therefore, quantiﬁcation of LacZ-expressing pericytes
may provide a simpliﬁed method for the quantiﬁcation of
pericyte loss in experimental diabetic retinopathy. Fur-
thermore, we showed that increased numbers of migrating
pericytes rise from pericytes that are LacZ negative. This is
in agreement with published data showing that prolifera-
tion and migration of LacZ-expressing cells are associated
with transgene downregulation and vessel injury leads to
changes in marker expression in pericyte subpopulations
(29).
The causes of early pericyte loss in diabetic retinopathy
have not been fully delineated. Numerous studies demon-
strated that increased levels of glucose and AGEs trigger
pericyte death in cell culture and that pericyte apoptosis is
increased in human diabetic retinas as well as in experi-
mental diabetic retinopathy (44–47). However, pericyte
apoptosis fails to explain the total extent of pericyte loss
and its time course in experimental diabetic retinopathy.
In animal models of diabetic retinopathy, pericyte apopto-
sis has been detected at later stages, after more than 6
months of hyperglycemia (31). Not compatible with this
observation is that signiﬁcant pericyte loss is already
detectable after 3 months of experimental diabetes (33).
Pericyte migration, as an alternative or additional mecha-
nism of pericyte loss in diabetic retinopathy, offers a
possible explanation for the discrepancy between total
extent of pericyte loss and published data of pericyte
apoptosis in the diabetic retina.
In summary, our data provide morphological evidence
that pericyte migration represents a novel mechanism of
pericyte loss in the diabetic retina. We further show that
this mechanism is regulated by signaling via the Ang-2/
Tie-2 pathway. The exact mechanism underlying this pro-
cess and the destiny of resting and migrating pericytes
remain to be investigated.
ACKNOWLEDGMENTS
This study was supported by grants from the Deutsche
Forschungsgemeinschaft (Graduiertenkolleg 880 to F.P.
and F.v.H.).
The authors thank Petra Bugert and Nadine Dietrich for
technical support. We thank Prof. B. Yard, Dr. H. Ko ¨ppel,
and E. Riedl for fruitful discussions. We thank Regeneron
Pharmaceuticals (Tarrytown, NJ) for providing transgenic
Ang2LacZ knock-in mice.
REFERENCES
1. Sims DE: Recent advances in pericyte biology: implications for health and
disease. Can J Cardiol 7:431–443, 1991
2. Sims DE: Diversity within pericytes. Clin Exp Pharmacol Physiol 27:842–
846, 2000
3. DeRuiter MC, Poelmann RE, VanMunsteren JC, Mironov V, Markwald RR,
Gittenberger-de Groot AC: Embryonic endothelial cells transdifferentiate
into mesenchymal cells expressing smooth muscle actins in vivo and in
vitro. Circ Res 80:444–451, 1997
4. Etchevers HC, Vincent C, Le Douarin NM, Couly GF: The cephalic neural
crest provides pericytes and smooth muscle cells to all blood vessels of the
face and forebrain. Development 128:1059–1068, 2001
5. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P: Adult
bone marrow-derived cells recruited during angiogenesis comprise precur-
sors for periendothelial vascular mural cells. Blood 104:2084–2086, 2004
6. Sundberg C, Ivarsson M, Gerdin B, Rubin K: Pericytes as collagen-
producing cells in excessive dermal scarring. Lab Invest 74:452–466, 1996
7. Thomas WE: Brain macrophages: on the role of pericytes and perivascular
cells. Brain Res Rev 31:42–57, 1999
8. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns. IV.
Diabetic retinopathy. Arch Ophthalmol. 66:366–378, 1961
9. Kuwabara T, Cogan DG: Retinal vascular patterns. VI. Mural cells of the
retinal capillaries. Arch Ophthalmol 69:492–502, 1963
10. Allt G, Lawrenson JG: Pericytes: cell biology and pathology. Cells Tissues
Organs 169:1–11, 2001
11. Bergers G, Song S: The role of pericytes in blood-vessel formation and
maintenance. Neuro-oncology 7:452–464, 2005
12. Peppiatt CM, Howarth C, Mobbs P, Attwell D: Bidirectional control of CNS
capillary diameter by pericytes. Nature 443:700–704, 2006
13. Joyce NC, Haire MF, Palade GE: Contractile proteins in pericytes. II.
Immunocytochemical evidence for the presence of two isomyosins in
graded concentrations. J Cell Biol 100:1387–1395, 1985
14. Joyce NC, Haire MF, Palade GE: Contractile proteins in pericytes. I.
Immunoperoxidase localization of tropomyosin. J Cell Biol 100:1379–1386,
1985
F. PFISTER AND ASSOCIATES
DIABETES, VOL. 57, SEPTEMBER 2008 250115. Nehls V, Drenckhahn D: Heterogeneity of microvascular pericytes for
smooth muscle type alpha-actin. J Cell Biol 113:147–154, 1999
16. Bauer HC, Steiner M, Bauer H: Embryonic development of the CNS
microvasculature in the mouse: new insights into the structural mecha-
nisms of early angiogenesis. Exs 61:64–68, 1992
17. Betsholtz C: Insight into the physiological functions of PDGF through
genetic studies in mice. Cytokine Growth Factor Rev 15:215–228, 2004
18. Egginton S, Zhou AL, Brown MD, Hudlicka ´ O: The role of pericytes in
controlling angiogenesis in vivo. Adv Exp Med Biol 476:81–99, 2000
19. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis.
Cell Tissue Res 314:15–23, 2003
20. Ozerdem U, Stallcup WB: Early contribution of pericytes to angiogenic
sprouting and tube formation. Angiogenesis 6:241–249, 2003
21. Wakui S, Yokoo K, Muto T, Suzuki Y, Takahashi H, Furusato M, Hano H,
Endou H, Kanai Y: Localization of Ang-1, -2, Tie-2, and VEGF expression at
endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 86:
1172–1184, 2006
22. Antonelli-Orlidge A, Smith SR, D’Amore PA: Inﬂuence of pericytes on
capillary endothelial cell growth. Am Rev Respir Dis 140:1129–1131, 1989
23. Hughes S, Chan-Ling T: Characterization of smooth muscle cell and
pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci
45:2795–2806, 2004
24. Armulik A, Abramsson A, Betsholtz C: Endothelial/pericyte interactions
Circ Res 97:512–523, 2005
25. Bondjers C, He L, Takemoto M, Norlin J, Asker N, Hellstro ¨m M, Lindahl P,
Betsholtz C: Microarray analysis of blood microvessels from PDGF-B and
PDGF-Rbeta mutant mice identiﬁes novel markers for brain pericytes.
FASEB J 20:1703–1705, 2006
26. Bondjers C, Kale ´n M, Hellstro ¨m M, Scheidl SJ, Abramsson A, Renner O,
Lindahl P, Cho H, Kehrl J, Betsholtz C: Transcription proﬁling of platelet-
derived growth factor-B-deﬁcient mouse embryos identiﬁes RGS5 as a
novel marker for pericytes and vascular smooth muscle cells. Am J Pathol
162:721–729, 2003
27. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH: Pericyte-speciﬁc
expression of Rgs5: implications for PDGF and EDG receptor signaling
during vascular maturation. FASEB J 17:440–442, 2003
28. Ozerdem U, Monosov E, Stallcup WB: NG2 proteoglycan expression by
pericytes in pathological microvasculature. Microvasc Res 63:129–134,
2002
29. Tidhar A, Reichenstein M, Cohen D, Faerman A, Copeland NG, Gilbert DJ,
Jenkins NA, Shani M: A novel transgenic marker for migrating limb muscle
precursors and for vascular smooth muscle cells. Dev Dyn 220:60–73, 2001
30. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee
M, Deutsch U: Pericytes and the pathogenesis of diabetic retinopathy.
Diabetes 51:3107–3112, 2002
31. Kowluru RA, Odenbach S: Effect of long-term administration of alpha-
lipoic acid on retinal capillary cell death and the development of retinop-
athy in diabetic rats. Diabetes 53:3233–3238, 2004
32. Mizutani M, Kern TS, Lorenzi M: Accelerated death of retinal microvascu-
lar cells in human and experimental diabetic retinopathy. J Clin Invest
97:2883–2890, 1996
33. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee
M, Deutsch U: Angiopoietin-2 causes pericyte dropout in the normal retina:
evidence for involvement in diabetic retinopathy. Diabetes 53:1104–1110,
2004
34. Feng Y, vom Hagen F, Pﬁster F, Djokic S, Hoffmann S, Back W, Wagner P,
Lin J, Deutsch U, Hammes HP: Impaired pericyte recruitment and abnor-
mal retinal angiogenesis as a result of angiopoietin-2 overexpression.
Thromb Haemost 97:99–108, 2007
35. Ohashi H, Takagi H, Koyama S, Oh H, Watanabe D, Antonetti DA,
Matsubara T, Nagai K, Arai H, Kita T, Honda Y: Alterations in expression
of angiopoietins and the Tie-2 receptor in the retina of streptozotocin
induced diabetic rats. Mol Vis 10:608–617, 2004
36. Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M,
Murakami T, Kimura T, Takagi H: Vitreous levels of angiopoietin 2 and
vascular endothelial growth factor in patients with proliferative diabetic
retinopathy. Am J Ophthalmol 139:476–481, 2005
37. vom Hagen F, Feng Y, Hillenbrand A, Hoffmann S, Shani M, Deutsch U,
Hammes HP: Early loss of arteriolar smooth muscle cells: more than just
a pericyte loss in diabetic retinopathy. Exp Clin Endocrinol Diabetes
113:573–576, 2005
38. Hackett SF, Wiegand S, Yancopoulos G, Campochiaro PA: Angiopoietin-2
plays an important role in retinal angiogenesis. J Cell Physiol 192:182–187,
2002
39. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R: Genetics of
diabetic retinopathy. Exp Clin Endocrinol Diabetes 114:275–294, 2006
40. Dore-Duffy P, Owen C, Balabanov R, Murphy S, Beaumont T, Rafols JA:
Pericyte migration from the vascular wall in response to traumatic brain
injury. Microvascular Research 60:55–69, 2000
41. Gonul E, Duz B, Kahraman S, Kayali H, Kubar A, Timurkaynak E: Early
pericyte response to brain hypoxia in cats: an ultrastructural study.
Microvasc Res 64:116–119, 2002
42. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM:
Cellular changes in normal blood capillaries undergoing regression after
inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290:H547–
H559, 2006
43. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, Suske
G, Rabbani N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M: High
glucose increases angiopoietin-2 transcription in microvascular endothe-
lial cells through methylglyoxal modiﬁcation of mSin3A. J Biol Chem
282:31038–31045, 2007
44. Chen BH, Jiang DY, Tang LS: Advanced glycation end-products induce
apoptosis involving the signaling pathways of oxidative stress in bovine
retinal pericytes. Life Sci 79:1040–1048, 2006
45. Kim J, Son JW, Lee JA, Oh YS, Shinn SH: Methylglyoxal induces apoptosis
mediated by reactive oxygen species in bovine retinal pericytes. J Korean
Med Sci 19:95–100, 2004
46. Li W, Yanoff M, Liu X, Ye X: Retinal capillary pericyte apoptosis in early
human diabetic retinopathy. Chin Med J (Engl) 110:659–663, 1997
47. Yang R, Liu H, Williams I, Chaqour B: Matrix metalloproteinase-2 expres-
sion and apoptogenic activity in retinal pericytes: implications in diabetic
retinopathy. Ann N Y Acad Sci 1103:196–201, 2007
PERICYTE MIGRATION IN DIABETIC RETINOPATHY
2502 DIABETES, VOL. 57, SEPTEMBER 2008